Patents by Inventor Ilia Tchoumakov

Ilia Tchoumakov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
    Publication number: 20060154295
    Abstract: The present invention concerns, in particular, human flavin-containing monooxygenase 2 (hFMO2), and another human enzyme of the FMO, hFMOx family, their nucleotide and polypeptide sequences. The present invention also concerns vectors for cloning and/or expression containing said nucleotide sequences and cells transformed by these vectors and method for preparing said polypeptides. The invention further concerns methods for selecting compounds and of diagnosing predisposition to pathologies and/or deficiencies related to FMO's and pharmaceutical compositions containing said compounds for treating and/or preventing these pathologies.
    Type: Application
    Filed: March 17, 2006
    Publication date: July 13, 2006
    Applicant: Serono Genetics Institute S.A.
    Inventors: Marta Blumenfeld, Ilia Tchoumakov, Henri-Jean Garchon, Jean-Francois Bach
  • Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
    Patent number: 7037709
    Abstract: The nucleotide and polypeptide sequences of two novel human flavin-containing monooxygenase (FMO) enzymes are presented: hFMO2 and hFMOx. Vectors and host cells for cloning and/or expression of hFMO2 and hFMOx are described, as are methods of preparing hFMO2 and hFMOx polypeptides. Also included are methods for selecting compounds, diagnosing predisposition to pathologies and/or deficiencies related to FMO's, and pharmaceutical compositions containing compounds for treating and/or preventing these pathologies.
    Type: Grant
    Filed: February 25, 2003
    Date of Patent: May 2, 2006
    Assignee: Serono Genetics Institute S.A.
    Inventors: Marta Blumenfeld, Ilia Tchoumakov, Henri-Jean Garchon, Jean-Francois Bach
  • Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
    Publication number: 20030203463
    Abstract: The nucleotide and polypeptide sequences of two novel human flavin-containing monooxygenase (FMO) enzymes are presented: hFMO2 and hFMOx. Vectors and host cells for cloning and/or expression of hFMO2 and hFMOx are described, as are methods of preparing hFMO2 and hFMOx polypeptides. Also included are methods for selecting compounds, diagnosing predisposition to pathologies and/or deficiencies related to FMO's, and pharmaceutical compositions containing compounds for treating and/or preventing these pathologies.
    Type: Application
    Filed: February 25, 2003
    Publication date: October 30, 2003
    Inventors: Marta Blumenfeld, Ilia Tchoumakov, Henri-Jean Garchon, Jean-Francois Bach
  • Biallelic markers for use in constructing a high density disequilibrium map of the human genome
    Publication number: 20030180773
    Abstract: The present invention relates to genomic maps comprising biallelic markers, new biallelic markers, and methods of using biallelic markers.
    Type: Application
    Filed: February 14, 2003
    Publication date: September 25, 2003
    Applicant: Genset S. A.
    Inventors: Daniel Cohen, Marta Blumenfeld, Ilia Tchoumakov
  • Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
    Patent number: 6551792
    Abstract: The present invention concerns, in particular, human flavin-containing monooxygenase 2 (hFMO2), and another human enzyme of the FMO, hFMOx family, their nucleotide and polypeptide sequences. The present invention also concerns vectors for cloning and/or expression containing said nucleotide sequences and cells transformed by these vectors and method for preparing said polypeptides. The invention further concerns methods for selecting compounds and of diagnosing predisposition to pathologies and/or deficiencies related to FMO's and pharmaceutical compositions containing said compounds for treating and/or preventing these pathologies.
    Type: Grant
    Filed: June 4, 1999
    Date of Patent: April 22, 2003
    Assignees: Genset, S.A., Institute National de la Sante et de la Recherche Medicale
    Inventors: Marta Blumenfeld, Ilia Tchoumakov, Henri-Jean Garchon, Jean-Francois Bach